Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat).

Mediators of Inflammation
Liliana FerreiraFlávio Reis

Abstract

The purpose of this paper is to evaluate the chronic effect of sitagliptin on metabolic profile, inflammation, and redox status in the Zucker Diabetic Fatty (ZDF) rat, an animal model of obese type 2 diabetes. Diabetic and obese ZDF (fa/fa) rats and their controls (ZDF +/+) were treated during 6 weeks with vehicle (control) and sitagliptin (10 mg/kg/bw). Glucose, HbA1c, insulin, Total-c, TGs, IL-1beta, TNF-alpha, CRPhs, and adiponectin were assessed in serum and MDA and TAS in serum, pancreas, and heart. Pancreatic histology was also evaluated. Sitagliptin in diabetic rats promoted a decrease in glucose, HbA1c, Total-c, and TGs accompanied by a partial prevention of insulinopenia, together, with a decrease in CRPhs and IL-1beta. Sitagliptin also showed a positive impact on lipid peroxidation and hypertension prevention. In conclusion, chronic sitagliptin treatment corrected the glycaemic dysmetabolism, hypertriglyceridaemia, inflammation, and hypertension, reduced the severity of the histopathological lesions of pancreatic endocrine and exocrine tissues, together with a favourable redox status, which might be a further advantage in the management of diabetes and its proatherogenic comorbidities.

References

May 1, 1983·Proceedings of the Society for Experimental Biology and Medicine·J B ClarkW N Shaw
Oct 24, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A FestaS M Haffner
May 29, 2002·The Journal of Biological Chemistry·Naoto KubotaTetsuo Noda
Nov 27, 2002·Circulation·Yoshihisa OkamotoYuji Matsuzawa
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Bo AhrénAnja Schweizer
Jun 28, 2005·Biochimica Et Biophysica Acta·Hans-Ulrich DemuthRaymond A Pederson
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
Oct 16, 2007·Diabetes Research and Clinical Practice·Kenji NonakaPeter P Stein
Feb 15, 2008·Diabetes Care·Marc Y DonathJan A Ehses
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jul 9, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ulf ForssmannStephan von Hörsten
Jul 22, 2008·Diabetes & Metabolism·A PenfornisD Raccah
Oct 14, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·E Mannucci, C M Rotella
Nov 26, 2008·Journal of Proteomics·Yannick BrunnerJean-Charles Sanchez
May 12, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·E MannucciN Marchionni
Jun 12, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M MonamiE Mannucci
Sep 15, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·M Nauck, U Smith
Sep 22, 2009·Current Opinion in Pharmacology·Patricia Pérez-MatuteJ Alfredo Martínez
Jan 1, 2008·Canadian Journal of Diabetes·Christopher H S McIntosh

❮ Previous
Next ❯

Citations

May 12, 2011·Journal of Cardiovascular Pharmacology·Nga N TaYan Huang
Jan 22, 2011·Journal of Biomedicine & Biotechnology·Sunil K Panchal, Lindsay Brown
Feb 11, 2012·Endocrine Reviews·John R Ussher, Daniel J Drucker
Sep 1, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Manuel Rosety-RodriguezFrancisco Javier Ordonez
Jan 6, 2011·Endocrine Journal·Sachiko Hattori
May 23, 2014·Drug Design, Development and Therapy·John Doupis
Aug 9, 2013·The Journal of Endocrinology·Franca S Angeli, Richard P Shannon
Jan 11, 2014·European Journal of Pharmacology·Bianca HemmeryckxH Roger Lijnen
Mar 14, 2014·Current Atherosclerosis Reports·Alison Cameron-VendrigMansoor Husain
Mar 29, 2014·Current Diabetes Reports·Angelo AvogaroGian Paolo Fadini
Mar 7, 2014·American Journal of Hypertension·Md Abdul Hye KhanJohn D Imig
Jul 3, 2013·Current Cardiology Reports·B SolunD Dicker
Feb 16, 2016·Fibrogenesis & Tissue Repair·Sen ShiKeizo Kanasaki
Jul 10, 2014·Kidney International·Tetsuhiro TanakaMasaomi Nangaku
Nov 3, 2015·Peptides·Flavio FranciniJuan José Gagliardino
Jun 28, 2011·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Leslie RitterJanet L Funk
Oct 2, 2012·Journal of Pineal Research·Ahmad AgilGumersindo Fernández-Vázquez
May 21, 2013·Journal of Diabetes·Yunjuan ZhaoZhiguang Zhou
Jun 22, 2013·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Zatollah AsemiAhmad Esmaillzadeh
Mar 14, 2012·Diabetes Research and Clinical Practice·Hamendra Singh ParmarAnil Kumar
Nov 19, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Veerle MatheeussenIngrid De Meester
Sep 25, 2014·Diabetes Care·Angelo Avogaro, Gian Paolo Fadini
May 13, 2014·Mediators of Inflammation·Catarina MarquesRosa Fernandes
Apr 30, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A L JoãoR Fernandes

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
MDA
light microscopy

Software Mentioned

GraphPad
GraphPadPrism

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.